Navigation Links
Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
Date:12/27/2010

MORRISTOWN, N.J., Dec. 27, 2010 /PRNewswire/ -- Vicus Therapeutics, LLC, today announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma), systemic inflammation and cachexia.  

The randomized, open label, multi-center Phase 2 study will evaluate whether VT-122 in combination with Nexavar increases "Clinical Benefit Response," which is a composite measurement of pain, performance status, and lean body mass, as compared to Nexavar alone.  The secondary efficacy endpoints of this study are cancer and cachexia specific symptoms, duration of Nexavar therapy and overall survival.

The study will be conducted under Vicus' US IND and is expected to enroll 80 patients with advanced liver cancer, systemic inflammation and cachexia at multiple sites in the United States.  Enrollment into this study is expected to be completed by the end of 2011. For more information about enrolling in the study, please visit www.clinicaltrial.gov.

Vicus Therapeutics, LLC, Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. have entered into an agreement pursuant to which Bayer and Onyx have agreed to support the study. The terms of the agreement are confidential.

About Cancer-induced Systemic Inflammation and Cachexia

The most common trajectory of the cancer patient is local progression, development of metastases, cancer-induced systemic inflammation and the associated symptom cluster of the anorexia-cachexia syndrome.  The anorexia-cachexia symptom cluster includes cachexia (anorexia, weight loss and muscle wasting), fatig
'/>"/>

SOURCE Vicus Therapeutics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics Records Last Patient Visit of Phase 2, VT-122 Trial for the Treatment of Cachexia in Patients With Advanced Lung Cancer
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®
4. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
5. Silence Therapeutics Provides Year-end Update
6. Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug
7. Talecris Biotherapeutics Enrolls Patients in Clinical Trial Evaluating Two Doses of PROLASTIN®-C
8. Osseon® Therapeutics Names Gary Coughlen, CPA as New Chief Financial Officer
9. Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinsons Disease
10. Orexigen® Therapeutics Investigational Drug Contrave® Receives Positive Recommendation from FDA Advisory Committee for Treatment of Obesity
11. Nile Therapeutics Receives NASDAQ Notice; Will Request Hearing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015  Unilife Corporation (NASDAQ: ... supplier of injectable drug delivery systems, announced today that ... of June 30, 2015. This amendment removed a covenant ... in cash receipts from customers during the six months ... to any of the terms of the debt agreement ...
(Date:7/1/2015)... 2015  LabStyle Innovations Corp. (DRIO), developer of ... appointment of Todd Durniak as Senior Vice President and ... LabStyle over 20 years of medical device commercial ... President and General Manager of Neighborhood Diabetes, a ... through durable medical equipment (DME) and pharmacy channels ...
(Date:7/1/2015)... Boston Scientific Corporation (NYSE: BSX ) will ... for the second quarter ended June 30, 2015 on Thursday, ... call will be hosted by Mike Mahoney , president ... vice president and chief financial officer. A live ... Boston Scientific website. Webcast registration is available on the Investor ...
Breaking Medicine Technology:Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 2LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 3LabStyle Innovations Appoints Senior VP & General Manager in U.S. for the Dario Diabetes Management Solution 4Boston Scientific To Webcast Second Quarter 2015 Earnings Call On July 23 2
... NEW YORK, Oct. 11, 2011 PLC Medical Systems, ... RetailInvestorConferences.com presentation is available for on-demand viewing. ... "register/ watch event now" button. PLC Medical ... Investors may download shareholder materials from the "virtual trade ...
... 11, 2011 I-Flow announced today ... purchasing agreement by HealthTrust Purchasing Group, L.P. (HealthTrust), ... covers I-Flow,s flagship ON-Q® products for incisional, nerve ... PainBuster®, ON-Q® SilverSoaker™ Catheters and ON-Q® disposable and ...
Cached Medicine Technology:PLC Medical Systems CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2I-Flow LLC, a Kimberly-Clark Health Care Company Announces Agreement for ON-Q® Products With HealthTrust Purchasing Group 2
(Date:7/1/2015)... ... July 01, 2015 , ... ... global distribution and marketing of a number of nutritional and beauty products, announced ... the 2015 ECRM Diet, Vitamin & Sports Nutrition conference in Tampa, Florida. This ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Thule Atmos X4 offers ... tested to ensure it lived up to Thule’s rigorous standards. Due to its Bi-ComponentArmor ... quality Thule owners have come to expect. , The Thule Atmos X4 ...
(Date:7/1/2015)... ... July 01, 2015 , ... AvePoint, ... announced the opening of a new operational office in Zurich, Switzerland. The new ... across all lines of business for organizations throughout the Swiss market. , ...
(Date:7/1/2015)... ... July 01, 2015 , ... RF ... solutions, has partnered with WIU Crossroads School in safeguarding its staff and students ... (Alternative Education for Disruptive Youth) environment of Crossroads School heightens the potential for ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... medical cannabis space, created a web-based resource where legal cannabis startups ... brings together visionary entrepreneurs and medical marijuana advocates looking to strategically enter and ...
Breaking Medicine News(10 mins):Health News:NPI Executives Report Great Success at ECRM Conference 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 2Health News:AvePoint Opens Office in Zurich to Meet Increasing Market Demand for Enterprise Collaboration Solutions in Switzerland 3Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 2Health News:WIU Crossroads School Chooses Help Alert Mobile Staff Duress Pendants from RF Technologies to Safeguard Staff and Students, De-escalate Altercations 3Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3
... in Higher Education (AGHE) the educational branch of ... its 37th Annual Meeting and Educational Leadership Conference ... Netherland Plaza in Cincinnati, OH. Media representatives are ... provides a forum for professionals in the field of aging ...
... , THURSDAY, Feb. 24 (HealthDay News) -- Fewer ... antigen (PSA) screening for prostate cancer since the release of ... a few years ago, say researchers. This study examined ... the decline in PSA screening was three percent among men ...
... - New findings by a University of Maryland-led team ... genes for a human anti-malarial antibody or a ... and environmentally friendly tool for combating malaria, at a ... mosquitoes is declining. In a study published in ...
... DC -- The U.S. Food and Drug Administration and ... partnership to stimulate innovation in regulatory science, ethics, education, ... institutions to meet their common goal of improving public ... and the unique opportunities for supporting our goal of ...
... THURSDAY, Feb. 24 (HealthDay News) -- Preliminary research suggests that ... stave off progression of the AIDS-causing virus. Although it,s ... findings of this small study raise the possibility that "there ... in HIV patients whether they,re taking AIDS medications or not," ...
... of the nation,s donor-liver distribution network developed by University ... people each year receiving the transplants they need. ... Science that donor livers currently are doled out ... for geography and demographics, an arrangement that prevents many ...
Cached Medicine News:Health News:As America's senior population grows, meeting to outline effective education about aging 2Health News:PSA Screening for Prostate Cancer Dips in Large U.S. Health Network 2Health News:New study shows ability of transgenic fungi to combat malaria and other bug-borne diseases 2Health News:New study shows ability of transgenic fungi to combat malaria and other bug-borne diseases 3Health News:New study shows ability of transgenic fungi to combat malaria and other bug-borne diseases 4Health News:FDA and Georgetown University Medical Center announce partnership 2Health News:Statins Might Help HIV Patients, Study Suggests 2Health News:Redesign of US donor-liver network could boost transplants by several hundred per year 2Health News:Redesign of US donor-liver network could boost transplants by several hundred per year 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: